| Pathologie | Prise en charge en Tunisie | |------------|----------------------------| | Leucémies aiguës | Chimiothérapie intensive, accès aux essais cliniques | | Lymphomes | Immunothérapie, radiothérapie, greffe autologue | | Myélome multiple | Thérapies ciblées (bortézomib, lénalidomide) | | Hémophilie / Willebrand | Centres de référence, facteurs de coagulation recombinants | | Drépanocytose | Dépistage néonatal, hydroxyurée, conseil génétique |
Tunisia offers both public and private options for hematological treatment, with several clinics receiving international recognition for oncology and hematology care: hematologue tunisie
Hematology services are organized into three tiers: | Pathologie | Prise en charge en Tunisie
The hematologist in Tunisia embodies a unique synthesis of clinical acumen, laboratory skill, and public health commitment. From managing sickle cell crises in the arid south to performing North Africa’s first haploidentical transplants, these physicians have built a discipline that saves lives under challenging conditions. Yet, the rapid pace of global hematology—with its CAR-T cells, gene editing, and personalized medicine—threatens to leave Tunisia behind unless strategic investments are made in molecular diagnostics, drug access, and human resource retention. For hématologue Tunisie to thrive in the next decade, it must move beyond survival to innovation, leveraging its regional leadership and strong French-speaking academic networks. The blood of the nation depends on it. For hématologue Tunisie to thrive in the next